| Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation IC Arnold, M Artola-Borán, P Tallón de Lara, A Kyburz, C Taube, ... Journal of experimental medicine, jem. 20172049, 2018 | 124 | 2018 |
| CD39+ PD-1+ CD8+ T cells mediate metastatic dormancy in breast cancer P Tallón de Lara, H Castañón, M Vermeer, N Núñez, K Silina, B Sobottka, ... Nature communications 12 (1), 1-14, 2021 | 64 | 2021 |
| Gemcitabine synergizes with immune checkpoint inhibitors and overcomes resistance in a preclinical model and mesothelioma patients P Tallón de Lara, V Cecconi, S Hiltbrunner, H Yagita, M Friess, ... Clinical Cancer Research, clincanres. 1231.2018, 2018 | 48 | 2018 |
| CSF1R-dependent myeloid cells are required for NK‑mediated control of metastasis M Beffinger, P Tallón de Lara, S Tugues, M Vermeer, Y Montagnolo, I Ohs, ... JCI insight 3 (10), 2018 | 41 | 2018 |
| Abstract GS4-08: Comprehensive genomic profiling of patients with breast cancer identifies germline-somatic interactions mediating therapy resistance A Safonov, C Bandlamudi, PT de Lara, E Ferraro, F Derakhshan, M Will, ... Cancer Research 82 (4_Supplement), GS4-08-GS4-08, 2022 | 26 | 2022 |
| Antimetastatic defense by CD8+ T cells P Tallón de Lara, H Castañón, M Sterpi, M van den Broek Trends in Cancer, 2021 | 14* | 2021 |
| A novel evidence-based predictor tool for hospitalization and length of stay: insights from COVID-19 patients in New York city M El Halabi, J Feghali, J Bahk, P Tallón de Lara, B Narasimhan, K Ho, ... Internal and Emergency Medicine 17 (7), 1879-1889, 2022 | 8 | 2022 |
| Comparing anticoagulation strategies for venous thromboembolism associated with active cancer: a systematic review and meta-analysis T Fujisaki, D Sueta, E Yamamoto, C Buckley, ... Cardio Oncology 6 (1), 99-113, 2024 | 6 | 2024 |
| Does telaprevir possess a direct antidiabetic effect? P Tallón de Lara, T Himschoot, JL Frossard, F Negro Liver International 34 (6), 967-969, 2014 | 6 | 2014 |
| Durable response after olaparib treatment for perihilar cholangiocarcinoma with germline BRCA2 mutation BA Costa, P Tallón de Lara, W Park, F Keane, JJ Harding, DN Khalil Oncology Research and Treatment 46 (5), 211-215, 2023 | 4 | 2023 |
| Primary pulmonary NUT carcinoma: case illustration and updated review of literature BA Costa, A Maraveyas, MH Wilkoff, GS de Camargo Correia, PT de Lara, ... Clinical Lung Cancer 23 (4), e296-e300, 2022 | 2 | 2022 |
| Immunogenomic characterization of biliary tract cancers: Biomarker enrichment for benefit to immune checkpoint blockade. W Park, F Keane, C Bandlamudi, M Donoghue, P Tallón de Lara, ... Journal of Clinical Oncology 40 (16_suppl), 4083-4083, 2022 | 2 | 2022 |
| CD39+ PD-1+ CD8+ T cells mediate metastatic dormancy in breast cancer P Tallón de Lara, H Castanon, M Vermeer, N Nunez, K Silina, B Sobottka, ... bioRxiv, 2020 | 2 | 2020 |
| Abstract GS3-03: Genomic analysis of 733 HER2+ breast cancers identifies recurrent pathways alterations associated with anti-HER2 resistance and new therapeutic vulnerabilities E Ferraro, A Smith, A Safonov, PT De Lara, C Bernado', EJA Lahuerta, ... Cancer Research 82 (4_Supplement), GS3-03-GS3-03, 2022 | | 2022 |
| 1122: NUT CARCINOMA OF THE LUNG WITH RAPID PROGRESSION TO ACUTE HYPOXEMIC RESPIRATORY FAILURE A Maraveyas, B Costa, PT De Lara, N Garg, J Salonia Critical Care Medicine 50 (1), 559, 2022 | | 2022 |
| A NOVEL EVIDENCE-BASED PREDICTOR TOOL FOR HOSPITALIZATION AND LENGTH OF STAY: INSIGHTS FROM PATIENTS WITH COVID-19 IN NEW YORK CITY M El Halabi, J Feghali, J Bahk, PT DE LARA, B Narasimhan, KS Ho, ... Chest 160 (4), A553-A554, 2021 | | 2021 |
| Abstract PO019: CD39+ PD-1+ CD8+ T cells mediate metastatic dormancy in breast cancer P Tallón de Lara, HC Cuadrado, M Vermeer, N Núñez, K Silina, ... Cancer Immunology Research 9 (2 Supplement), PO019-PO019, 2021 | | 2021 |
| Tu1394 LOWER ESOPHAGEAL SPHINCTER AND PERISTALTIC PRESSURES INCREASE WITH AGE IN PATIENTS WITHOUT A MAJOR ABNORMALITY ON HIGH RESOLUTION ESOPHAGEAL MANOMETRY M El Halabi, X Zhang, PT de Lara, E Verheyen, MS Smith Gastroenterology 158 (6), S-1088, 2020 | | 2020 |
| CD39+ PD-1+ CD8+ T cells mediate metastatic dormancy in breast cancer P Tallón de Lara, H Castanon, M Vermeer, N Nunez, K Silina, B Sobottka, ... bioRxiv, 2020 | | 2020 |
| Spontaneous and Therapy-induced Control of Disseminated Cancer by T-cells P Tallón de Lara Universität Zürich, 2019 | | 2019 |
Maries van den BroekInstitute of Experimental Immunology, University of Zurich在 immunology.uzh.ch 的电子邮件经过验证
